The notices it replaced
3 notices since 2015, oldest first, each with its awards since FY2014.
- Posted 2015RFA-HL-16-02469 awards
- Posted 2019RFA-HL-20-01135 awards
- Posted 2021RFA-HL-23-00436 awards
- Posted 2024RFA-HL-26-002This notice, open · 15 awards
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 155
- 155 new
- Median first-year cost
- $948,730
- $143,450,996 in all
- Institutions
- 66
- 129 contact PIs
- Patents
- 21
- from 15 funded projects
Awards by fiscal year
0
0
0
31
22
16
13
12
10
10
12
14
15
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES11
- UNIVERSITY OF MICHIGAN AT ANN ARBOR8
- UNIVERSITY OF CALIFORNIA LOS ANGELES6
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO6
- YALE UNIVERSITY6
and 61 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-I (O1))78
- Special Emphasis Panel (ZHL1 CSR-R (O3))37
- Special Emphasis Panel (ZHL1 CSR-R (O1))13
- Special Emphasis Panel (ZHL1 CSR-I (O2))12
- Special Emphasis Panel (ZRG1 RCCS-K (90))6
and 3 other study sections
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2026 | Non-coding RNAs and chronic limb threatening ischemia1R35HL183402-01 | Feinberg, Mark W | BRIGHAM AND WOMEN'S HOSPITAL, MA | First-year cost $1,242,222 | Study section ZRG1 |
| FY2026 | Bridging the gap between basic and clinical research to prevent cardiovascular disease in diabetes1R35HL184266-01 | Bornfeldt, Karin E | UNIVERSITY OF WASHINGTON, WA | First-year cost $1,233,682 | Study section ZRG1 |
| FY2026 | A Program Investigating New Concepts ofMacrophage Biology in Atherosclerosis and Atherosclerosis-MASH Cardiometabolic Disease1R35HL183005-01 | Tabas, Ira A | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $1,151,500 | Study section ZRG1 |
| FY2026 | Regenerate the lung through a better understanding of development1R35HL184263-01 | Que, Jianwen | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $1,151,498 | Study section ZRG1 |
| FY2026 | Dynamics and plasticity of the hematopoietic stem cell niche1R35HL184177-01 | Ding, Lei | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $1,137,883 | Study section ZRG1 |
| FY2026 | Therapeutic editing for cardiovascular diseases1R35HL183558-01 | Musunuru, Kiran | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $1,137,435 | Study section ZRG1 |
| FY2026 | Regulation of Ubiquitin E3 ligases and Innate Immunity in ARDS1R35HL182842-01 | Mallampalli, Rama K | OHIO STATE UNIVERSITY, OH | First-year cost $1,102,500 | Study section ZRG1 |
| FY2026 | Program to block age-related pulmonary fibrosis and restore lung regeneration1R35HL183538-01 | Chapman, Harold A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $1,097,760 | Study section ZRG1 |
| FY2026 | Interorganellar Calcium Signaling in Health and Disease1R35HL183468-01 | Trebak, Mohamed | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $1,088,692 | Study section ZRG1 |
| FY2026 | Novel pathways and mechanisms underlying disorders of platelet count and/or function1R35HL183547-01 | Bergmeier, Wolfgang | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $1,081,420 | Study section ZRG1 |
| FY2026 | Decoding kindlin-3 signaling in platelets and neutrophils1R35HL183465-01 | Ma, Yan-Qing | VERSITI BLOOD HEALTH, INC., WI | First-year cost $1,069,072 | Study section ZRG1 |
| FY2026 | Screening and validation of miRNA targets for neurogenic hypertension.1R35HL184169-01 | Lazartigues, Eric D | LSU HEALTH SCIENCES CENTER, LA | First-year cost $1,008,719 | Study section ZRG1 |
| FY2026 | The protein C pathway: Mechanisms, Structure-function, and Translation1R35HL184173-01 | Mosnier, Laurent Olivier | SCRIPPS RESEARCH INSTITUTE, THE, CA | First-year cost $863,954 | Study section ZRG1 |
| FY2026 | Leveraging the nutrient sensing and degradative capacity of lysosomes in macrophages as a novel therapeutic approach in cardiovascular disease1R35HL183548-01 | Razani, Babak | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $756,607 | Study section ZRG1 |
| FY2026 | Decoding the enigma of cardiac arrhythmia and mechanosensitivity1R35HL184262-01 | Chiamvimonvat, Nipavan | UNIVERSITY OF ARIZONA, AZ | First-year cost $558,127 | Study section ZRG1 |
| FY2025 | Molecular and Translational Studies in Hematologic Disorders1R35HL177719-01 · under RFA-HL-23-004 | Lopez, Jose Aron | BLOODWORKS, WA | First-year cost $1,276,908 | Study section ZHL1 |
| FY2025 | Advancing Precision Medicine for ARDS and Sepsis1R35HL177135-01 · under RFA-HL-23-004 | Calfee, Carolyn | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $1,147,992 | Study section ZHL1 |
| FY2025 | Locking and Unlocking Cardiac Maturation1R35HL177035-01 · under RFA-HL-23-004 | Kelly, Daniel Patrick | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $1,137,498 | Study section ZHL1 |
| FY2025 | Macrophages in Cardiovascular Health1R35HL176359-01 · under RFA-HL-23-004 | Nahrendorf, Matthias | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $1,127,798 | Study section ZHL1 |
| FY2025 | The microenvironment in bone marrow hematopoiesis1R35HL177125-01 · under RFA-HL-23-004 | Lucas, Daniel | CINCINNATI CHILDRENS HOSP MED CTR, OH | First-year cost $1,123,357 | Study section ZHL1 |
| FY2025 | Molecular Mechanism and Targeting of Chronic Pain in Sickle Cell Disease1R35HL177406-01 · under RFA-HL-23-004 | Wang, Zaijie Jim | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | First-year cost $1,103,783 | Study section ZHL1 |
| FY2025 | The role of cancer in cardiovascular disease1R35HL176060-01 · under RFA-HL-23-004 | Leeper, Nicholas James | STANFORD UNIVERSITY, CA | First-year cost $1,102,957 | Study section ZHL1 |
| FY2025 | Regulation of Intravascular Triglyceride Hydrolysis1R35HL176438-01 · under RFA-HL-23-004 | Young, Stephen G. | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $1,102,500 | Study section ZHL1 |
| FY2025 | Intersection of the PPARγ-RhoBTB1-Cullin-3 Pathway and Renin-Angiotensin System in Blood Pressure, Vascular Function and Arterial Stiffness1R35HL177123-01 · under RFA-HL-23-004 | Sigmund, Curt Daniel | MEDICAL COLLEGE OF WISCONSIN, WI | First-year cost $1,092,000 | Study section ZHL1 |
| FY2025 | Phagocyte Crosstalk in the Balance of Inflammation & Cardiac Disease1R35HL177401-01 · under RFA-HL-23-004 | Thorp, Edward Benjamin | NORTHWESTERN UNIVERSITY, IL | First-year cost $1,091,824 | Study section ZHL1 |
| FY2025 | CD4+ T cell Immunity in the Respiratory Tract1R35HL177381-01 · under RFA-HL-23-004 | Kolls, Jay K | TULANE UNIVERSITY OF LOUISIANA, LA | First-year cost $1,063,324 | Study section ZHL1 |
| FY2025 | Immune crosstalk in lung injury and fibrosis1R35HL176572-01 · under RFA-HL-23-004 | Moore, Bethany B. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $1,061,189 | Study section ZHL1 |
| FY2025 | Promoting weight-related health in the next generation of adolescents and young adults:A comprehensive program of research1R35HL177136-01 · under RFA-HL-23-004 | Neumark-Sztainer, Dianne R | UNIVERSITY OF MINNESOTA, MN | First-year cost $1,057,905 | Study section ZHL1 |
| FY2025 | Targeting Hypoxia-Inducible Factors (HIFs) for Heart and Lung Disease1R35HL177402-01 · under RFA-HL-23-004 | Eltzschig, Holger K. | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | First-year cost $564,445 | Study section ZHL1 |
| FY2024 | Developmental origins of pericyte heterogeneity1R35HL171534-01 · under RFA-HL-23-004 | Lawson, Nathan D | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | First-year cost $1,172,500 | Study section ZHL1 |
| FY2024 | Emergency Myelopoiesis in the Control of Blood Production1R35HL171521-01 · under RFA-HL-23-004 | Passegue, Emmanuelle | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $1,131,261 | Study section ZHL1 |
| FY2024 | From genetic association to function: pleiotropic novel genes and variants linking lipid metabolism and cardiovascular diseases1R35HL172107-01 · under RFA-HL-23-004 | Rader, Daniel James | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $1,123,889 | Study section ZHL1 |
| FY2024 | Transcriptional and epigenetic mechanisms of alveologenesis and re-alveologenesis1R35HL171346-01 · under RFA-HL-23-004 | Chen, Jichao | CINCINNATI CHILDRENS HOSP MED CTR, OH | First-year cost $1,122,351 | Study section ZHL1 |
| FY2024 | Heterozygous SERPINE1 Deficiency Confers Durable Cardiovascular Fitness in Humans1R35HL171553-01 · under RFA-HL-23-004 | Vaughan, Douglas E | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | First-year cost $1,114,010 | Study section ZHL1 |
| FY2024 | Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension1R35HL171538-01 · under RFA-HL-23-004 | Yuan, Jason X J | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $1,106,000 | Study section ZHL1 |
| FY2024 | Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in Cardiomyopathy1R35HL171080-01 · under RFA-HL-23-004 | Dorn, Gerald W. | WASHINGTON UNIVERSITY, MO | First-year cost $1,088,500 | Study section ZHL1 |
| FY2024 | Cardiovascular potassium channels: From molecular basis to disease therapeutics1R35HL171542-01 · under RFA-HL-23-004 | Nichols, Colin G | WASHINGTON UNIVERSITY, MO | First-year cost $1,088,500 | Study section ZHL1 |
| FY2024 | Neural Control of Breathing1R35HL171451-01 · under RFA-HL-23-004 | Feldman, Jack L | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $1,088,345 | Study section ZHL1 |
| FY2024 | Molecular and Cellular Regulation of Vascular Calcification1R35HL171342-01 · under RFA-HL-23-004 | Giachelli, Cecilia M | UNIVERSITY OF WASHINGTON, WA | First-year cost $1,067,521 | Study section ZHL1 |
| FY2024 | Mechanisms in Blood Clotting1R35HL171334-01 · under RFA-HL-23-004 | Morrissey, James H. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $988,138 | Study section ZHL1 |
| FY2024 | The Molecular Genetics of Hemostasis1R35HL171421-01 · under RFA-HL-23-004 | Ginsburg, David | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $941,106 | Study section ZHL1 |
| FY2023 | Inflammation and thrombosis fuel cardiovascular and pulmonary disease: Focus on the interplay of neutrophil inflammasomes with NETs1R35HL166556-01 · under RFA-HL-23-004 | Wagner, Denisa D | BOSTON CHILDREN'S HOSPITAL, MA | First-year cost $1,239,000 | Study section ZHL1 |
| FY2023 | Regulation of Progenitor Cell Plasticity in Lung Development and Disease-Repair1R35HL166661-01 · under RFA-HL-23-004 | Cardoso, Wellington V. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $1,117,873 | Study section ZHL1 |
| FY2023 | Decoding innate immune signaling in normal and myelodysplastic hematopoiesis1R35HL166430-01 · under RFA-HL-23-004 | Starczynowski, Daniel | CINCINNATI CHILDRENS HOSP MED CTR, OH | First-year cost $1,113,000 | Study section ZHL1 |
| FY2023 | Mechanical Load Effects on Cardiac Function and Heart Diseases1R35HL166575-01 · under RFA-HL-23-004 | Chen-Izu, Ye | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | First-year cost $1,101,935 | Study section ZHL1 |
| FY2023 | GPIb-IX and VWF in thrombosis and thrombocytopenia1R35HL166654-01 · under RFA-HL-23-004 | Li, Renhao | EMORY UNIVERSITY, GA | First-year cost $1,095,500 | Study section ZHL1 |
| FY2023 | Supply and Demand: Oxygen and Workload Regulate Cardiomyocyte Proliferation1R35HL166563-01 · under RFA-HL-23-004 | Sadek, Hesham | UT SOUTHWESTERN MEDICAL CENTER, TX | First-year cost $1,071,753 | Study section ZHL1 |
| FY2023 | Targeted immune therapies in heart transplantation1R35HL166640-01 · under RFA-HL-23-004 | Abdi, Reza | BRIGHAM AND WOMEN'S HOSPITAL, MA | First-year cost $1,050,893 | Study section ZHL1 |
| FY2023 | Pathogenic Exosomes in COPD1R35HL166433-01 · under RFA-HL-23-004 | Blalock, J Edwin | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | First-year cost $1,026,066 | Study section ZHL1 |
| FY2023 | Dysregulated Immunometabolism and Premature Senescence in Corticosteroid-Refractory Severe Asthma1R35HL166219-01 · under RFA-HL-23-004 | Ray, Anuradha | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $743,410 | Study section ZHL1 |
| FY2023 | Intersection of Obesity and Heart Failure with Preserved Ejection Fraction1R35HL166565-01 · under RFA-HL-23-004 | Kass, David Alan | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $736,477 | Study section ZHL1 |
| FY2022 | The Centrosome as a master controller of platelet production.1R35HL161175-01 · under RFA-HL-20-011 | Italiano, Joseph E | BOSTON CHILDREN'S HOSPITAL, MA | First-year cost $1,062,000 | Study section ZHL1 |
| FY2022 | Patient-specific Outcome Prediction from Cardiovascular Multimodality Imaging by Artificial Intelligence1R35HL161195-01 · under RFA-HL-20-011 | Slomka, Piotr J | CEDARS-SINAI MEDICAL CENTER, CA | First-year cost $1,027,005 | Study section ZHL1 |
| FY2022 | Molecular Atlas of the Cardiac Intercalated Disc1R35HL160840-01 · under RFA-HL-20-011 | Delmar, Mario | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | First-year cost $998,006 | Study section ZHL1 |
| FY2022 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema1R35HL161238-01 · under RFA-HL-20-011 | Majka, Susan M | NATIONAL JEWISH HEALTH, CO | First-year cost $996,000 | Study section ZHL1 |
| FY2022 | Investigating Individual Susceptibility and Host Response in Acute Respiratory Distress Syndrome1R35HL161196-01 · under RFA-HL-20-011 | Meyer, Nuala Jennings | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $975,000 | Study section ZHL1 |
| FY2022 | New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial Fibrillation1R35HL161249-01 · under RFA-HL-20-011 | Arora, Rishi | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | First-year cost $960,000 | Study section ZHL1 |
| FY2022 | Cell competition in pulmonary fibrosis and ARDS1R35HL161169-01 · under RFA-HL-20-011 | De Langhe, Stijn Piet Johan | MAYO CLINIC ROCHESTER, MN | First-year cost $954,000 | Study section ZHL1 |
| FY2022 | Connexin-based Signaling in the Heart: Cellular and Exosomal1R35HL161237-01 · under RFA-HL-20-011 | Gourdie, Robert G | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | First-year cost $874,987 | Study section ZHL1 |
| FY2022 | Immune Pathophysiology of Sickle Cell Disease1R35HL161239-01 · under RFA-HL-20-011 | Yazdanbakhsh, Karina | NEW YORK BLOOD CENTER, NY | First-year cost $846,806 | Study section ZHL1 |
| FY2022 | Immunobiology of the normal and injured lung1R35HL161241-01 · under RFA-HL-20-011 | Looney, Mark Roberts | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $566,011 | Study section ZHL1 |
| FY2021 | Human and mouse transcriptome profiling identifies cross-species homology of mononuclear phagocytes1R35HL155458-01 · under RFA-HL-20-011 | Jakubzick, Claudia V | DARTMOUTH COLLEGE, NH | First-year cost $984,000 | Study section ZHL1 |
| FY2021 | Novel signaling molecules regulating platelet activation1R35HL155694-01 · under RFA-HL-20-011 | Kunapuli, Satya P. | TEMPLE UNIV OF THE COMMONWEALTH, PA | First-year cost $950,997 | Study section ZHL1 |
| FY2021 | Neurobiology of the Bronchopulmonary System1R35HL155671-01 · under RFA-HL-20-011 | Undem, Bradley Joel | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $938,076 | Study section ZHL1 |
| FY2021 | Insights into the molecular mechanisms regulating vascular and immune metabolism in vascular diseases1R35HL155988-01 · under RFA-HL-20-011 | Suarez, Yajaira | YALE UNIVERSITY, CT | First-year cost $936,044 | Study section ZHL1 |
| FY2021 | Endogenous circadian mechanisms underlying cardiovascular risk1R35HL155681-01 · under RFA-HL-20-011 | Shea, Steven A | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $924,000 | Study section ZHL1 |
| FY2021 | Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level1R35HL155318-01 · under RFA-HL-20-011 | Rosenzweig, Anthony | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $909,471 | Study section ZHL1 |
| FY2021 | Tissue factor-dependent coagulation in thrombosis and immune responses1R35HL155657-01 · under RFA-HL-20-011 | Mackman, Nigel | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $863,736 | Study section ZHL1 |
| FY2021 | TRP channels as fundamental sensors of the cerebral microcirculation1R35HL155008-01 · under RFA-HL-20-011 | Earley, Scott | UNIVERSITY OF NEVADA RENO, NV | First-year cost $862,070 | Study section ZHL1 |
| FY2021 | Transendothelial Migration of Leukocytes: Developing New Paradigms in Health and Disease1R35HL155652-01 · under RFA-HL-20-011 | Muller, William A | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | First-year cost $848,469 | Study section ZHL1 |
| FY2021 | Mechanisms addressing the causal relationships of sleep, circadian rhythms, and cardiometabolic health1R35HL155670-01 · under RFA-HL-20-011 | St-Onge, Marie-Pierre | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $815,838 | Study section ZHL1 |
| FY2021 | Determinants of Aorta Heterogeneity1R35HL155649-01 · under RFA-HL-20-011 | Daugherty, Alan | UNIVERSITY OF KENTUCKY, KY | First-year cost $596,149 | Study section ZHL1 |
| FY2021 | Role of mitophagy in age-related respiratory and vascular diseases1R35HL155169-01 · under RFA-HL-20-011 | Goldstein, Daniel Robert | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $585,000 | Study section ZHL1 |
| FY2020 | New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets1R35HL150698-01 · under RFA-HL-20-011 | Poncz, Mortimer | CHILDREN'S HOSP OF PHILADELPHIA, PA | First-year cost $1,056,000 | Study section ZHL1 |
| FY2020 | Identifying new strategies for prevention of cardiovascular complications of diabetes1R35HL150754-01 · under RFA-HL-20-011 | Bornfeldt, Karin E. | UNIVERSITY OF WASHINGTON, WA | First-year cost $1,037,755 | Study section ZHL1 |
| FY2020 | Adaptable tissue-specific endothelial cells for organ regeneration1R35HL150809-01 · under RFA-HL-20-011 | Rafii, Shahin | WEILL MEDICAL COLL OF CORNELL UNIV, NY | First-year cost $1,032,314 | Study section ZHL1 |
| FY2020 | Novel vascular smooth muscle cell progenitors in development and disease1R35HL150766-01 · under RFA-HL-20-011 | Greif, Daniel | YALE UNIVERSITY, CT | First-year cost $1,003,144 | Study section ZHL1 |
| FY2020 | Platelet Exocytosis and Endocytosis in Thrombosis and Immunity1R35HL150818-01 · under RFA-HL-20-011 | Whiteheart, Sidney Waldo | UNIVERSITY OF KENTUCKY, KY | First-year cost $970,913 | Study section ZHL1 |
| FY2020 | Program to promote lung regeneration and block fibrosis1R35HL150767-01 · under RFA-HL-20-011 | Chapman, Harold A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $965,500 | Study section ZHL1 |
| FY2020 | Leveraging zebrafish models to dissect and enhance heart regeneration1R35HL150713-01 · under RFA-HL-20-011 | Poss, Kenneth D | DUKE UNIVERSITY, NC | First-year cost $960,647 | Study section ZHL1 |
| FY2020 | Mechanisms of integrin signaling and a new anti-platelet/anti-inflammatory approach1R35HL150797-01 · under RFA-HL-20-011 | Du, Xiaoping | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | First-year cost $959,400 | Study section ZHL1 |
| FY2020 | Ca2+ Signaling Networks in Health and Disease1R35HL150778-01 · under RFA-HL-20-011 | Trebak, Mohamed | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | First-year cost $944,709 | Study section ZHL1 |
| FY2020 | Vascular Barrier Leakage in Inflammation1R35HL150732-01 · under RFA-HL-20-011 | Yuan, Sarah Y | UNIVERSITY OF SOUTH FLORIDA, FL | First-year cost $893,838 | Study section ZHL1 |
| FY2020 | Cell-cell interactions governing lung epithelial progenitor cells1R35HL150876-01 · under RFA-HL-20-011 | Kim, Carla F. | BOSTON CHILDREN'S HOSPITAL, MA | First-year cost $885,000 | Study section ZHL1 |
| FY2020 | Molecular Regulation of Progressive Pulmonary Fibrosis1R35HL150829-01 · under RFA-HL-20-011 | Noble, Paul Wesley | CEDARS-SINAI MEDICAL CENTER, CA | First-year cost $847,538 | Study section ZHL1 |
| FY2020 | Viral and allergen-driven immunity in chronic lung disease1R35HL150682-01 · under RFA-HL-20-011 | Lukacs, Nicholas W | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $684,921 | Study section ZHL1 |
| FY2019 | Molecular and Translational Studies in Hematologic Disorders1R35HL145262-01 · under RFA-HL-16-024 | Lopez, Jose Aron | BLOODWORKS, WA | First-year cost $1,105,665 | Study section ZHL1 |
| FY2019 | Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia1R35HL144980-01 · under RFA-HL-16-024 | Knollmann, Bjorn C | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | First-year cost $1,020,000 | Study section ZHL1 |
| FY2019 | Airway epithelial cell gene regulation: new mechanisms and therapeutic strategies1R35HL145235-01 · under RFA-HL-16-024 | Erle, David J | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $961,617 | Study section ZHL1 |
| FY2019 | A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques1R35HL145228-01 · under RFA-HL-16-024 | Tabas, Ira A | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $955,996 | Study section ZHL1 |
| FY2019 | Defining and Controlling Airway Disease1R35HL145242-01 · under RFA-HL-16-024 | Holtzman, Michael J | WASHINGTON UNIVERSITY, MO | First-year cost $939,000 | Study section ZHL1 |
| FY2019 | Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis1R35HL144979-01 · under RFA-HL-16-024 | Peters-Golden, Marc L | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $928,378 | Study section ZHL1 |
| FY2019 | Vascular macrophages and T cells in atherosclerosis1R35HL145241-01 · under RFA-HL-16-024 | Ley, Klaus F. | LA JOLLA INSTITUTE FOR IMMUNOLOGY, CA | First-year cost $927,585 | Study section ZHL1 |
| FY2019 | PPARG-dependent Mechanisms Control Endothelial-Smooth Muscle Coordination, Arterial Pressure, Vasomotor Function and Arterial Stiffness1R35HL144807-01 · under RFA-HL-16-024 | Sigmund, Curt Daniel | MEDICAL COLLEGE OF WISCONSIN, WI | First-year cost $924,000 | Study section ZHL1 |
| FY2019 | Organizational strategies for improving evidence-uptake in intensive care1R35HL144804-01 · under RFA-HL-16-024 | Kahn, Jeremy M | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $922,387 | Study section ZHL1 |
| FY2019 | Capillaries as a Sensory Web that Controls Cerebral Blood Flow in Health and Disease1R35HL140027-01 · under RFA-HL-16-024 | Nelson, Mark T | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | First-year cost $919,963 | Study section ZHL1 |
| FY2019 | Role of the giant protein titin in cardiac health and disease1R35HL144998-01 · under RFA-HL-16-024 | Granzier, Henk L. | UNIVERSITY OF ARIZONA, AZ | First-year cost $884,369 | Study section ZHL1 |
| FY2019 | Renewing the heart: cardiomyocyte cell cycle regulation1R35HL144984-01 · under RFA-HL-16-024 | Evans, Sylvia M | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $865,334 | Study section ZHL1 |
| FY2019 | Immunobiology of Lung Injury and Fibrosis1R35HL144481-01 · under RFA-HL-16-024 | Moore, Bethany B. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $847,613 | Study section ZHL1 |
| FY2019 | Cilia in Heart Development and Disease1R35HL145249-01 · under RFA-HL-16-024 | Brueckner, Martina | YALE UNIVERSITY, CT | First-year cost $726,127 | Study section ZHL1 |
| FY2019 | Small GTPases in the biology of platelets and megakaryocytes1R35HL144976-01 · under RFA-HL-16-024 | Bergmeier, Wolfgang | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $561,180 | Study section ZHL1 |
| FY2019 | Translational Control of Megakaryocyte and Platelet Gene Expression in Disease1R35HL145237-01 · under RFA-HL-16-024 | Weyrich, Andrew S | UNIVERSITY OF UTAH, UT | First-year cost $253,797 | Study section ZHL1 |
| FY2018 | Insights into the Molecular and Cellular Mechanisms governing Endothelial Function1R35HL139945-01 · under RFA-HL-16-024 | Sessa, William C | YALE UNIVERSITY, CT | First-year cost $1,005,000 | Study section ZHL1 |
| FY2018 | Embryonic origins of endothelial heterogeneity1R35HL140017-01 · under RFA-HL-16-024 | Lawson, Nathan D | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | First-year cost $1,005,000 | Study section ZHL1 |
| FY2018 | Imaging organ system interfaces in ischemic heart disease1R35HL139598-01 · under RFA-HL-16-024 | Nahrendorf, Matthias | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $987,881 | Study section ZHL1 |
| FY2018 | Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells1R35HL139937-01 · under RFA-HL-16-024 | Newman, Peter J | VERSITI WISCONSIN, INC., WI | First-year cost $986,967 | Study section ZHL1 |
| FY2018 | Cardiac lineage determination and nuclear architecture1R35HL140018-01 · under RFA-HL-16-024 | Epstein, Jonathan A. | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $957,952 | Study section ZHL1 |
| FY2018 | CaMKII signaling in physiology, heart failure and arrhythmias1R35HL140034-01 · under RFA-HL-16-024 | Anderson, Mark E | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $950,658 | Study section ZHL1 |
| FY2018 | Tie2-driven vascular control in critical illness1R35HL139424-01 · under RFA-HL-16-024 | Parikh, Samir M | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | First-year cost $939,488 | Study section ZHL1 |
| FY2018 | Mechanisms of vascular and valvular calcification1R35HL139602-01 · under RFA-HL-16-024 | Giachelli, Cecilia M | UNIVERSITY OF WASHINGTON, WA | First-year cost $931,250 | Study section ZHL1 |
| FY2018 | Eating, Activity, and Weight-Related Problems Across the Life Course in Diverse Populations1R35HL139853-01 · under RFA-HL-16-024 | Neumark-Sztainer, Dianne R | UNIVERSITY OF MINNESOTA, MN | First-year cost $927,214 | Study section ZHL1 |
| FY2018 | Vascular Growth and Regeneration1R35HL140014-01 · under RFA-HL-16-024 | Iruela-Arispe, M. Luisa | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $924,642 | Study section ZHL1 |
| FY2018 | MOLECULAR AND CELLULAR CONTROL OF ANGIOGENESIS1R35HL139950-01 · under RFA-HL-16-024 | Bautch, Victoria L | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $922,296 | Study section ZHL1 |
| FY2018 | Potassium Channels and Control of Cardiovascular Function1R35HL140024-01 · under RFA-HL-16-024 | Nichols, Colin G | WASHINGTON UNIVERSITY, MO | First-year cost $915,000 | Study section ZHL1 |
| FY2018 | CD4_T-cell_Immunity_in_the_Lung1R35HL139930-01 · under RFA-HL-16-024 | Kolls, Jay K | TULANE UNIVERSITY OF LOUISIANA, LA | First-year cost $860,539 | Study section ZHL1 |
| FY2018 | Variant Hemoglobin and Cardiorespiratory Regulation in Humans1R35HL139854-01 · under RFA-HL-16-024 | Joyner, Michael J | MAYO CLINIC ROCHESTER, MN | First-year cost $806,184 | Study section ZHL1 |
| FY2018 | Biochemistry and Pathophysiology of Factor XI and Contact Activation1R35HL140025-01 · under RFA-HL-16-024 | Gailani, David | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | First-year cost $790,000 | Study section ZHL1 |
| FY2018 | Genomics of Pulmonary Vascular Disease1R35HL140019-01 · under RFA-HL-16-024 | Aldred, Micheala A | INDIANA UNIVERSITY INDIANAPOLIS, IN | First-year cost $777,434 | Study section ZHL1 |
| FY2018 | Investigating Mechanisms for Lipid Transport in Health and Disease1R35HL139725-01 · under RFA-HL-16-024 | Young, Stephen G. | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $775,320 | Study section ZHL1 |
| FY2018 | Deconvoluting the Vascular Adhesome1R35HL139947-01 · under RFA-HL-16-024 | Ginsberg, Mark Howard | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $774,183 | Study section ZHL1 |
| FY2018 | Controlling Influences of Oxygen Tension and CD26/DPP4 Enzymatic Activity on Regulation of Hematopoietic Stem/Progenitor Cells and Hematopoiesis During Health, Ageing, and Disease1R35HL139599-01 · under RFA-HL-16-024 | Broxmeyer, Hal E. | INDIANA UNIVERSITY INDIANAPOLIS, IN | First-year cost $768,104 | Study section ZHL1 |
| FY2018 | Mechanisms of Immune Activation in Hypertension1R35HL140016-01 · under RFA-HL-16-024 | Harrison, David G | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | First-year cost $767,077 | Study section ZHL1 |
| FY2018 | Molecular mechanism and targeting of chronic pain in sickle cell disease1R35HL140031-01 · under RFA-HL-16-024 | Wang, Zaijie Jim | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | First-year cost $661,398 | Study section ZHL1 |
| FY2018 | SOD3 regulation of redox sensitive signaling in pulmonary vascular diseases1R35HL139726-01 · under RFA-HL-16-024 | Nozik, Eva S. | UNIVERSITY OF COLORADO DENVER, CO | First-year cost $571,435 | Study section ZHL1 |
| FY2017 | Phenotypic and Molecular Signatures for Sleep Apnea and Related Morbidities1R35HL135818-01 · under RFA-HL-16-024 | Redline, Susan S. | BRIGHAM AND WOMEN'S HOSPITAL, MA | First-year cost $1,057,510 | Study section ZHL1 |
| FY2017 | The Identification and characterization of genetic variants underlying cardiovascular diseases1R35HL135767-01 · under RFA-HL-16-024 | Mani, Arya | YALE UNIVERSITY, CT | First-year cost $1,005,000 | Study section ZHL1 |
| FY2017 | Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease1R35HL135827-01 · under RFA-HL-16-024 | Kass, David Alan | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $994,861 | Study section ZHL1 |
| FY2017 | Beyond the barrier: alveolar epithelial cell biology in health and disease1R35HL135747-01 · under RFA-HL-16-024 | Borok, Zea | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | First-year cost $990,000 | Study section ZHL1 |
| FY2017 | Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men1R35HL135833-01 · under RFA-HL-16-024 | Ginsberg, Henry N | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $953,882 | Study section ZHL1 |
| FY2017 | KLF control of aging and age-associated cardiovascular disease1R35HL135789-01 · under RFA-HL-16-024 | Jain, Mukesh Kumar | CASE WESTERN RESERVE UNIVERSITY, OH | First-year cost $951,000 | Study section ZHL1 |
| FY2017 | Mechanisms Controlling Expansion and Lineage Specification of Airway Progenitors in Development and Disease1R35HL135834-01 · under RFA-HL-16-024 | Cardoso, Wellington V. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $948,730 | Study section ZHL1 |
| FY2017 | AIBP therapy1R35HL135737-01 · under RFA-HL-16-024 | Miller, Yury | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $930,000 | Study section ZHL1 |
| FY2017 | Mechanisms of sphingolipid signaling in vascular health and disease1R35HL135821-01 · under RFA-HL-16-024 | Hla, Timothy Tun | BOSTON CHILDREN'S HOSPITAL, MA | First-year cost $926,656 | Study section ZHL1 |
| FY2017 | S-glutathionylation chemistry in fibrotic lung remodeling1R35HL135828-01 · under RFA-HL-16-024 | Janssen-Heininger, Yvonne M. W. | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | First-year cost $923,815 | Study section ZHL1 |
| FY2017 | THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASE1R35HL135736-01 · under RFA-HL-16-024 | Dorn, Gerald W. | WASHINGTON UNIVERSITY, MO | First-year cost $915,000 | Study section ZHL1 |
| FY2017 | Signaling mechanisms and functions related to patho-physiology of vascular, lung and blood systems1R35HL135805-01 · under RFA-HL-16-024 | Wu, Dianqing | YALE UNIVERSITY, CT | First-year cost $912,314 | Study section ZHL1 |
| FY2017 | Omics Phenotyping for Identifying Molecular Signatures of the Healthy and Failing Heart: An Integrated Data Science Platform1R35HL135772-01 · under RFA-HL-16-024 | Ping, Peipei | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $910,734 | Study section ZHL1 |
| FY2017 | Defining novel mechanisms for human arrhythmia1R35HL135754-01 · under RFA-HL-16-024 | Mohler, Peter J. | OHIO STATE UNIVERSITY, OH | First-year cost $908,050 | Study section ZHL1 |
| FY2017 | How inflammation and thrombosis fuel disease and aging: Focus on NETs1R35HL135765-01 · under RFA-HL-16-024 | Wagner, Denisa D | BOSTON CHILDREN'S HOSPITAL, MA | First-year cost $885,000 | Study section ZHL1 |
| FY2017 | A Novel Exosomal Inflammatory Pathway1R35HL135710-01 · under RFA-HL-16-024 | Blalock, J Edwin | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | First-year cost $877,566 | Study section ZHL1 |
| FY2017 | Pneumonia Biology1R35HL135756-01 · under RFA-HL-16-024 | Mizgerd, Joseph P | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | First-year cost $868,938 | Study section ZHL1 |
| FY2017 | Pediatric Heart Disease: Getting from Mutations to Therapeutics1R35HL135742-01 · under RFA-HL-16-024 | Gelb, Bruce D | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | First-year cost $856,106 | Study section ZHL1 |
| FY2017 | Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis1R35HL135799-01 · under RFA-HL-16-024 | Moore, Kathryn J | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | First-year cost $823,175 | Study section ZHL1 |
| FY2017 | Emergency Myelopoiesis Pathways in the Control of Blood Production1R35HL135763-01 · under RFA-HL-16-024 | Passegue, Emmanuelle | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $816,806 | Study section ZHL1 |
| FY2017 | A Gata456 Pipeline of Discovery1R35HL135778-01 · under RFA-HL-16-024 | Evans, Todd R | WEILL MEDICAL COLL OF CORNELL UNIV, NY | First-year cost $810,723 | Study section ZHL1 |
| FY2017 | Innate Immune Clearance of Host-Adapted Pulmonary Pathogens1R35HL135800-01 · under RFA-HL-16-024 | Prince, Alice S | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $796,640 | Study section ZHL1 |
| FY2017 | Neural control of breathing1R35HL135779-01 · under RFA-HL-16-024 | Feldman, Jack L | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | First-year cost $781,655 | Study section ZHL1 |
| FY2017 | Role of LDL receptor family members in protecting the vasculature1R35HL135743-01 · under RFA-HL-16-024 | Strickland, Dudley K. | UNIVERSITY OF MARYLAND BALTIMORE, MD | First-year cost $770,872 | Study section ZHL1 |
| FY2017 | Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension1R35HL135807-01 · under RFA-HL-16-024 | Yuan, Jason X J | UNIVERSITY OF ARIZONA, AZ | First-year cost $767,500 | Study section ZHL1 |
| FY2017 | The Molecular Genetics of Hemostasis1R35HL135793-01 · under RFA-HL-16-024 | Ginsburg, David | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $578,742 | Study section ZHL1 |
| FY2017 | Thiol Isomerases in Hemostasis and Thrombosis1R35HL135775-01 · under RFA-HL-16-024 | Flaumenhaft, Robert C | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | First-year cost $432,500 | Study section ZHL1 |
| FY2017 | Macrophages in homeostasis and cardiovascular disease1R35HL135752-01 · under RFA-HL-16-024 | Swirski, Filip K | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $427,500 | Study section ZHL1 |
| FY2017 | Structure-Function and Roles of Protease-Activated Receptors1R35HL135755-01 · under RFA-HL-16-024 | Coughlin, Shaun R. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $396,250 | Study section ZHL1 |
| FY2017 | Therapeutic Implications of Molecular Defects in Bone Marrow Failure1R35HL135795-01 · under RFA-HL-16-024 | Maciejewski, Jaroslaw P. | CLEVELAND CLINIC LERNER COM-CWRU, OH | First-year cost $396,250 | Study section ZHL1 |
| FY2017 | Mechanisms in Blood Clotting1R35HL135823-01 · under RFA-HL-16-024 | Morrissey, James H. | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | First-year cost $311,265 | Study section ZHL1 |
Newest fiscal year first, then first-year cost.
Patents from its funded projects
21 patents name 15 of the 155 funded projects. The newest 5, by patent number.
- US 12,725,261 (opens the patent at USPTO, a PDF, in a new tab)CONVOLUTIONAL LONG SHORT-TERM MEMORY NETWORKS FOR RAPID MEDICAL IMAGE SEGMENTATIONGranted September 1, 2026 to CEDARS-SINAI MEDICAL CENTERR35HL161195 · CEDARS-SINAI MEDICAL CENTER, CA
- US 12,714,678 (opens the patent at USPTO, a PDF, in a new tab)PEPTIDES AND METHODS OF TREATING SEPSIS, ATHEROSCLEROSIS, THROMBOSIS, STROKE, HEART ATTACK AND INFLAMMATIONGranted August 25, 2026 to The Board of Trustees of the University of IllinoisR35HL150797 · UNIVERSITY OF ILLINOIS AT CHICAGO, IL
- US 12,678,433 (opens the patent at USPTO, a PDF, in a new tab)COMPOUNDS FOR TREATMENT OF HEMOLYSIS-AND INFLAMMASOME-ASSOCIATED DISEASESGranted July 14, 2026 to New York Blood Center, Inc.R35HL161239 · NEW YORK BLOOD CENTER, NY
- US 12,661,390 (opens the patent at USPTO, a PDF, in a new tab)ADAMTS13 TREATMENT TO ENHANCE GRAFT SURVIVALGranted June 23, 2026 to THE CHILDREN'S MEDICAL CENTER CORPORATIONR35HL135765 · BOSTON CHILDREN'S HOSPITAL, MA
- US 12,583,920 (opens the patent at USPTO, a PDF, in a new tab)COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASEGranted March 24, 2026 to UNIVERSITY OF MARYLAND, BALTIMORE and THE GENERAL HOSPITAL CORPORATIONR35HL135743 · UNIVERSITY OF MARYLAND BALTIMORE, MD
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.